Let's Talk Oral Biologics
Source: Biosimilar Development

The development of an oral biologic would surely revolutionize the biologics industry. But so far, this journey has been fraught with challenges. Here, Biosimilar Development Chief Editor poses a question about what the future of oral biologics efforts might look like--especially in light of growing pressures for the biosimilar industry to differentiate.
This website uses cookies to ensure you get the best experience on our website. Learn more